Lung biopsy in infants with severe bronchopulmonary dysplasia
Pediatric Pulmonology · 2023
DOI: 10.1002/ppul.26433 ↗At a glance
Journal article in Pediatric Pulmonology, 2023. Written by Danielle A Callaway and 7 co-authors. Institution: Department of Pediatrics, Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Bronchopulmonary Dysplasia, Lung Diseases, Interstitial. Cited 3 times so far (Crossref); 24 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS, NICHD NIH HHS, National Institutes of Health.
Abstract (original language)
Introduction
Lung biopsy is infrequently performed in the population of infants with severe bronchopulmonary dysplasia (BPD). Yet, its presentation may overlap with other infant diffuse lung diseases, including those within the spectrum of childhood interstitial lung diseases (chILD). Lung biopsy might differentiate between these entities or identify those with an extremely poor prognosis. Both might alter the clinical management of some infants diagnosed with BPD.
Methods
In this tertiary referral center, we drew on a retrospective cohort of 308 preterm infants with severe BPD. Of these, nine underwent lung biopsy between 2012 and 2017. We aimed to assess the indication for lung biopsy, the prior clinical history, safety of the procedure, and describe the biopsy findings. Finally, we considered management decisions in relation to the biopsy results in these patients.
Results
All nine infants undergoing biopsy survived the procedure. The mean gestational age and birth weight of the nine patients were 30 ± 3 (range 27−34) weeks and 1421 ± 571 (range 611−2140) grams. All infants received serial echocardiograms to assess pulmonary hypertension, genetic testing, and computed tomography angiography (CTA) before biopsy. In all nine patients moderate to severe alveolar simplification was present and eight had some degree of pulmonary interstitial glycogenosis (PIG) ranging from focal to diffuse. Following biopsy, two infants with PIG received high dose systemic steroids and two separate infants had care redirected.
Conclusion
In our cohort, lung biopsy was safe and well tolerated. Findings from lung biopsy may aid decision making in selected patients as a part of a step‐wise diagnostic algorithm.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pediatrics, Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Neonatology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
- Department of Pathology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Division of General, Thoracic and Fetal Surgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Emeritus, Pediatrics, McMaster University, Hamilton, Ontario, Canada.
- Emeritus, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID profiles: Danielle A Callaway
Funding
- NHLBI NIH HHS
- NICHD NIH HHS
- National Institutes of Health
Cite
APA
Callaway, D. A., Wang, Y., Lingappan, K., Pogoriler, J. E., Laje, P., Nilan, K., Kirpalani, H., & Zhang, H. (2023). Lung biopsy in infants with severe bronchopulmonary dysplasia. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26433
Vancouver
Callaway DA, Wang Y, Lingappan K, Pogoriler JE, Laje P, Nilan K, et al. Lung biopsy in infants with severe bronchopulmonary dysplasia. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26433
BibTeX
@article{Callaway2023,
author = {Callaway, Danielle A and Wang, Yifei and Lingappan, Krithika and Pogoriler, Jennifer E and Laje, Pablo and Nilan, Kathleen and Kirpalani, Haresh and Zhang, Huayan},
title = {Lung biopsy in infants with severe bronchopulmonary dysplasia},
journal = {Pediatric Pulmonology},
year = {2023},
doi = {10.1002/ppul.26433}
}
EUVIMED